sglt2 inhibitors vs glp 1 Renal outcomes of and GLP1 agonists in clinical practice SGLT-2 inhibitors or GLP-1 receptor

Tirzepatide is slightly different (it is both GIP and GLP-1 - it has lower GLP-1 activity than semaglutide , but much higher GIP activity)

In 2024, Ozempic was the third-best-selling drug in the country, with sales growing by 25 percent from 2023, which had already been a blockbuster year, with nearly $40 billion in sales

These drugs were first approved to help regulate blood sugar in people with type 2 diabetes but were later discovered to promote weight loss, among other health benefits

Instead, they prioritize foods that help maintain fullness and digestive balance

Slower gastric emptying also changes the digestive experience

As our understanding of HFpEF evolves, GLP-1RAs have the potential to become a cornerstone of therapy, addressing the multifactorial nature of this condition and improving outcomes in a challenging patient population